AXT: Capturing the InP Wave — A High-Conviction Long with a Measured Stop

Hook / Thesis

AXT has shifted from a cyclical substrate supplier into a strategic supplier for AI data-center optical interconnects. The company reported record quarterly revenue and margin expansion, backed by a >$100M backlog and roughly $748.8M of liquidity after a secondary offering. That combination - accelerating top-line, improving gross margins and the cash to scale - is a rare triad in small-cap industrial semicap equipment.

Because the market is already pricing strong growth, this is not a low-volatility trade. But the setup is actionable: bullish momentum, short interest that can fuel squeezes, and objective operational milestones (capacity targets and 6-inch wafer progression) that should continue to re-rate the story if execution stays on track. Below I lay out why AXT matters, concrete numbers that support the case, a clear trade plan with time horizon and stop, and the key risks that could derail the move.

What AXT Does and Why the Market Should Care

AXT, Inc. designs and manufactures compound and single-element semiconductor substrates, including indium phosphide (InP) wafers that are increasingly critical for high-speed optical lasers and photonic engines used in AI data-center interconnects. Hyperscalers and optical-module OEMs need higher-performance substrates to scale optical links between AI accelerators and racks; AXT supplies that substrate step.

The market cares because demand for InP is structurally growing. AXT isn't just a marginal supplier - it now has a large backlog and explicit capacity plans that move it from a boutique supplier to a scaled vendor for cloud customers. That changes both revenue visibility and margin potential.

Supporting Evidence - Numbers That Matter

• Record Q2 2026 revenue of $47.6M, up 165% year-over-year, and reported gross margins of 44.9% (09/18/2026 commentary).
• Management cited a backlog greater than $100M and plans to push InP capacity to roughly $35M of quarterly revenue by end-2026 and $65-70M by 2027 / early 2028 (09/09/2026 and 09/18/2026 updates).
• Balance-sheet strength: roughly $748.8M in liquidity following an April secondary, which management has earmarked for aggressive InP capacity expansion (09/09/2026).
• Market-cap and valuation: the stock trades around a $5.36B market-cap with price-to-sales in the 40x neighborhood (ratios snapshot). That premium reflects an expectation of rapid revenue scaling and durable margin expansion.
• Technicals and market dynamics: current price action shows bullish momentum - the 10-day SMA sits below price and MACD is positive. Average daily volume is near 8.9M shares, with short-interest levels that equate to roughly 1-1.3 days to cover on recent settlement dates, meaning squeezes are possible in fast moves.

Valuation Framing

At a market cap of roughly $5.36B and reported trailing revenue run-rates moving quickly higher, AXT is priced for significant growth. Price-to-sales in the low-to-mid 40s implies the market expects robust top-line expansion and sustained high gross margins. That premium is tolerable if management hits capacity and backlog conversion targets; it is vulnerable if revenue growth slips or margins compress.

AXT's reported EPS is small (the most recent reported EPS per share is approximately $0.06 on the ratios snapshot), and the company is still in a scaling phase where revenue and margin trajectory are more informative than trailing EPS. Enterprise-value metrics show EV roughly in line with market-cap (enterprise value near $5.04B), and free cash flow was modestly negative in the latest snapshot, reflecting reinvestment into capacity.

Trade Plan (actionable)

Thesis: Buy into accelerating InP revenue and backlog conversion as the company ramps to multi-quarter capacity milestones. Use a measured stop to protect capital if execution falters.

Why these levels?

• Entry $82.00: near current trading levels and recent intraday action, providing a reasonable point to enter without chasing an extended gap higher.
• Target $140.00: reflects a move back toward the 52-week high of $143.16 and prices in successful conversion of backlog and the planned capacity increases across 2026-2028. Achieving this target implies the market believes AXT will meaningfully grow revenue and sustain margins.
• Stop $70.00: a clear technical and fundamental stop below short-term support and below a level that would indicate deterioration of the growth narrative or a material miss on backlog conversion.
• Horizon: long term (180 trading days). Capacity expansions and backlog conversions are multi-quarter stories; giving the trade ~6-9 months (46-180 trading days) allows the company to execute on capital projects, convert backlog to revenue and show margin progression.

Catalysts to Watch

• Quarterly results and guidance: continued sequential revenue growth and maintenance or expansion of gross margins will validate the thesis.
• Capacity milestones: confirmation of $35M quarterly revenue run-rate by end-2026 and subsequent expansion toward $65-70M by 2027/early 2028.
• Backlog conversion and new long-term supply agreements: any additional multi-year contracts with hyperscalers or large optical OEMs.
• Progress on 6-inch wafer qualification: moving from smaller substrates to 6-inch would materially increase addressable revenue and competitiveness.
• Macro optical spending by hyperscalers: continued hyperscaler capex into AI interconnects will sustain demand for InP substrates.

Risks and Counterarguments

Investors must weigh several meaningful risks. I list the principal ones and include a counterargument to the bull case.

• Execution risk on capacity build - expanding InP lines is capital- and time-intensive. Delays, cost overruns, or lower-than-expected yield at 6-inch scale would compress margins and slow revenue conversion.
• Demand concentration / macro risk - AXT's current strength is tied to hyperscaler AI optical spending. A slowdown in hyperscaler capex or a shift in optical architecture preferences could reduce demand.
• Competitive pressure and supply-chain dynamics - Competitors like Coherent and Lumentum are also expanding optics and InP capabilities. If those firms vertically integrate or undercut pricing, AXT's pricing power could weaken.
• Valuation vulnerability - trading at a premium (P/S in the 40x range) leaves little room for disappointment. Any revenue or margin miss is likely to trigger a sharp re-rate given the elevated expectations.
• Geopolitical / export control risk - supply-chain or export restrictions, especially with China, could affect the company's addressable markets or its customers' ability to buy.

Counterargument: the bull case depends heavily on continued hyperscaler optical spending and flawless capital deployment. If customers diversify suppliers or demand growth slows, AXT's premium multiple will compress quickly. In that scenario, even solid execution might not prevent a share-price decline because expectations are so high.

Why this trade, not buy-and-forget?

This is a catalytic growth trade tied to execution milestones. The long-term structural tailwind for InP is intact, but near-term upside is conditional on hitting capacity and backlog conversion targets. The suggested stop protects capital if execution slips; the target captures much of the upside if the company demonstrates durable revenue and margin expansion.

What Would Change My Mind

I would downgrade this trade if any of the following occur:

• Failure to convert backlog at the expected cadence or materially lower-than-forecast revenue in the next two quarters.
• Significant margin compression (gross margin falling well below 40% on a sustained basis), suggesting pricing pressure or yield issues.
• Material dilution beyond the April raise, or a pivot in capital deployment away from InP capacity expansion.
• Clear evidence that major hyperscaler customers are switching to alternative suppliers or reducing optical interconnect spending materially.

Conclusion - Clear Stance

I am constructive and recommend a long position with disciplined risk control: enter at $82.00, target $140.00, stop $70.00, and give the trade a long-term horizon of 180 trading days. AXT's record revenue, improving margins, large backlog and cash cushion create an asymmetric payoff if the company executes on capacity expansion and InP demand continues. That said, valuation is premium and execution risk is real; the stop is essential.

Key event calendar to monitor: next two quarterly results, management commentary on capacity timing and 6-inch wafer qualification, and any large supply-agreements or customer wins.

Trade responsibly: stay size-aware and use the stop. If AXT misses targets, the premium valuation could reverse quickly.